Search Results - "Lima, Camilo H. da S."

Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT) by Albuquerque, Suraby O., Barros, Thalita G., Dias, Luiza R.S., Lima, Camilo H. da S., Azevedo, Pedro H.R. de A., Flores-Junior, Luiz A.P., dos Santos, Eldio G., Loponte, Hector F., Pinheiro, Sergio, Dias, Wagner B., Muri, Estela M.F., Todeschini, Adriane R.

“…The vital enzyme O-linked β-N-acetylglucosamine transferase (OGT) catalyzes the O-GlcNAcylation of intracellular proteins coupling the metabolic status to…”
Get full text

Synthesis and antimycobacterial activity of N′-[( E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives by Vergara, Fátima M.F., Lima, Camilo H. da S., Henriques, Maria das Graças M. de O., Candéa, André L.P., Lourenço, Maria C.S., Ferreira, Marcelle de L., Kaiser, Carlos R., de Souza, Marcus V.N.

“…The present article describes a series of twenty-six N′-[( E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide ( 4– 29), which were synthesized and…”
Get full text

Hydroxyl group interactions in metal dithiocarbamate complexes containing 2-hydroxyethyl substituents. Crystal structure determination, theoretical and Hirshfeld surface study of tris(2-hydroxyethyl(ethyl)amino-dithiocarbamato)indium(III). Survey of hydroxyl group interactions in metal tris(dithiocarbamato) complexes containing 2-hydroxyethyl substituents by de Lima, Geraldo M., Lima, Camilo H. da S., Machado, Sergio de P., da Silva, Everton T., da Silva, Talis U., Wardell, James L., Wardell, Solange M.S.V.

“…•X-ray determination of the crystal structures of tris(2-hydroxyethyl(ethyl)amino-dithiocarbamato)indium(III).•DFT calculations on…”
Get full text

Isosorbide-based peptidomimetics as inhibitors of hepatitis C virus serine protease by Portela, Aline C., Barros, Thalita G., Lima, Camilo H. da S., Dias, Luiza R.S., Azevedo, Pedro H.R. de A., Dantas, Anna Sophia C.L., Mohana-Borges, Ronaldo, Ventura, Gustavo T., Pinheiro, Sergio, Muri, Estela M.F.

“…[Display omitted] Hepatitis C infection is a cause of chronic liver diseases such as cirrhosis and carcinoma. The current therapy for hepatitis C has limited…”
Get full text